CORONA Remedies Limited (BOM:544644)
India · Delayed Price · Currency is INR 1,498.90
-44.70 (-2.90%)
At close: Apr 2, 2026
CORONA Remedies Market Cap
CORONA Remedies has a market cap or net worth of 91.69 billion as of April 2, 2026.
Market Cap
91.69B
Enterprise Value
91.78B
Revenue
13.44B
Ranking
n/a
PE Ratio
53.51
Stock Price
1,498.90
Market Cap Chart
Since December 15, 2025, CORONA Remedies's market cap has increased from 87.97B to 91.69B, an increase of 4.23%. That is a compound annual growth rate of 15.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 91.69B | 8.25% |
| Dec 31, 2025 | 84.70B | -3.72% |
| Dec 15, 2025 | 87.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca Pharma India | 196.32B |
| Granules India | 152.15B |
| Jubilant Pharmova | 133.01B |
| Rubicon Research | 128.85B |
| Caplin Point Laboratories | 119.62B |
| CORONA Remedies | 91.69B |
| Viyash Scientific | 83.73B |
| Procter & Gamble Health | 79.80B |